BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32475753)

  • 1. Mucosa-associated microbiota in the jejunum of patients with morbid obesity: alterations in states of insulin resistance and metformin treatment.
    Gutiérrez-Repiso C; Moreno-Indias I; Martín-Núñez GM; Ho-Plágaro A; Rodríguez-Cañete A; Gonzalo M; García-Fuentes E; Tinahones FJ
    Surg Obes Relat Dis; 2020 Oct; 16(10):1575-1585. PubMed ID: 32475753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jejunal gluconeogenesis associated with insulin resistance level and its evolution after Roux-en-Y gastric bypass.
    Gutierrez-Repiso C; Garcia-Serrano S; Moreno-Ruiz FJ; Alcain-Martinez G; Rodriguez-Pacheco F; Garcia-Fuentes E
    Surg Obes Relat Dis; 2017 Apr; 13(4):623-630. PubMed ID: 28089435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of genes involved in jejunal lipogenesis and lipoprotein synthesis is altered in morbidly obese subjects with insulin resistance.
    Gutierrez-Repiso C; Rodriguez-Pacheco F; Garcia-Arnes J; Valdes S; Gonzalo M; Soriguer F; Moreno-Ruiz FJ; Rodriguez-Cañete A; Gallego-Perales JL; Alcain-Martinez G; Vazquez-Pedreño L; Lopez-Enriquez S; Garcia-Serrano S; Garrido-Sanchez L; Garcia-Fuentes E
    Lab Invest; 2015 Dec; 95(12):1409-17. PubMed ID: 26367490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jejunal Insulin Signalling Is Increased in Morbidly Obese Subjects with High Insulin Resistance and Is Regulated by Insulin and Leptin.
    Gutierrez-Repiso C; Ho-Plagaro A; Santiago-Fernandez C; Garcia-Serrano S; Rodríguez-Pacheco F; Valdes S; Garrido-Sanchez L; Rodríguez-Díaz C; López-Gómez C; Moreno-Ruiz FJ; Alcain-Martinez G; Gautier-Stein A; Mithieux G; Garcia-Fuentes E
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of β-cell dysfunction and insulin resistance correlating obesity with type 2 diabetes: A cross-sectional study.
    Liu J; Wang Y; Hu Y; Leng S; Wang G
    J Diabetes Complications; 2016 Jul; 30(5):898-902. PubMed ID: 27012460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variant organic cation transporter 2 (OCT2)-T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin.
    Kashi Z; Masoumi P; Mahrooz A; Hashemi-Soteh MB; Bahar A; Alizadeh A
    Diabetes Res Clin Pract; 2015 Apr; 108(1):78-83. PubMed ID: 25662675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
    Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
    mBio; 2018 May; 9(3):. PubMed ID: 29789365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue biomarkers involved in early resolution of type 2 diabetes after bariatric surgery.
    Garrido-Sánchez L; Tomé M; Santiago-Fernández C; García-Serrano S; García-Fuentes E; Tinahones FJ
    Surg Obes Relat Dis; 2017 Jan; 13(1):70-77. PubMed ID: 27317602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial.
    Molina-Vega M; Picón-César MJ; Gutiérrez-Repiso C; Fernández-Valero A; Lima-Rubio F; González-Romero S; Moreno-Indias I; Tinahones FJ
    Biomed Pharmacother; 2022 Jan; 145():112465. PubMed ID: 34844107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota of Chinese Obese Children and Adolescents With and Without Insulin Resistance.
    Yuan X; Chen R; Zhang Y; Lin X; Yang X; McCormick KL
    Front Endocrinol (Lausanne); 2021; 12():636272. PubMed ID: 33815293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats.
    Zhong MW; Liu SZ; Zhang GY; Zhang X; Liu T; Hu SY
    World J Gastroenterol; 2016 Aug; 22(29):6706-15. PubMed ID: 27547013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of laparoscopic sleeve gastrectomy on insulin secretion patterns in morbidly obese patients].
    Qian C; Zhu C; Gao J; Bu L; Zhou D; Li N; Qu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):61-67. PubMed ID: 29354901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of SGLT2i on the GH/IGF1 axis in newly diagnosed male T2D patients - a prospective, randomized case-control study.
    Lin J; Zhan L; Chen Z; Lin X; Zhu R
    Endocrine; 2024 Apr; 84(1):203-212. PubMed ID: 38168834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
    Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
    Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
    Ferjan S; Janez A; Jensterle M
    Endocr Pract; 2018 Jan; 24(1):69-77. PubMed ID: 29144805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lower duodenal immune response is associated with an increase of insulin resistance in patients with morbid obesity.
    Ho-Plagaro A; Santiago-Fernandez C; García-Serrano S; Rodriguez C; Garrido-Sanchez L; Escamilla A; Gonzalo M; Montiel-Casado C; Alcaín-Martínez G; Garcia-Muñoz B; Ruiz-Santana N; Vázquez-Pedreño L; Garcia-Fuentes E
    Int J Obes (Lond); 2020 Feb; 44(2):340-352. PubMed ID: 31554917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance predicts steatosis and fibrosis in morbidly obese patients undergoing bariatric surgery.
    Aller R; de Luis D; Pacheco D; Velasco MC; Izaola O; Sagrado MG
    J Investig Med; 2012 Oct; 60(7):1005-8. PubMed ID: 22847342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationship of Gut Microbiota, Obesity, Body Composition and Insulin Resistance in Asians with Type 2 Diabetes Mellitus.
    Pai CS; Wang CY; Hung WW; Hung WC; Tsai HJ; Chang CC; Hwang SJ; Dai CY; Ho WY; Tsai YC
    J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
    Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
    Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.